These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9165505)

  • 21. [Efficacy and safety of high-dose toremifene for hormone-responsive advanced or metastatic breast cancer patients with failed prior treatment by aromatase inhibitors].
    Ohtake T; Yasuda M; Watanabe K; Ito T; Ito J; Miyamoto K; Yoshida S; Abe N; Ishigame T; Ishii M; Kimijima I; Takenoshita S
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1459-63. PubMed ID: 19755813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical trial of fadrozole hydrochloride for postmenopausal patients with recurrent breast cancer].
    Kanzaki M; Nakaya Y; Kojima K; Toda H; Tobayama S; Machida H; Ohba M
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):959-65. PubMed ID: 10396324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experience of hormonal therapy with anastrozole for previously treated metastatic breast cancer.
    Lavrenkov K; Man S; Geffen DB; Cohen Y
    Isr Med Assoc J; 2002 Mar; 4(3):176-7. PubMed ID: 11908256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of letrozole for advanced breast cancer in postmenopausal patients.
    Ansari TN; Mahmood A; Hussain I; Samad A
    J Coll Physicians Surg Pak; 2005 Apr; 15(4):204-6. PubMed ID: 15857590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aminoglutethimide in the treatment of advanced postmenopausal breast cancer.
    Harris AL; Powles TJ; Smith IE
    Cancer Res; 1982 Aug; 42(8 Suppl):3405s-3408s. PubMed ID: 7083207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of first-line letrozole versus tamoxifen as a function of age in postmenopausal women with advanced breast cancer.
    Mouridsen H; Chaudri-Ross HA
    Oncologist; 2004; 9(5):497-506. PubMed ID: 15477634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase III, double-blind, controlled trial of atamestane plus toremifene compared with letrozole in postmenopausal women with advanced receptor-positive breast cancer.
    Goss P; Bondarenko IN; Manikhas GN; Pendergrass KB; Miller WH; Langecker P; Blanchett D
    J Clin Oncol; 2007 Nov; 25(31):4961-6. PubMed ID: 17971594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy of treatment with high-dose toremifene in patients with metastatic breast cancer resistant to aromatase inhibitor treatment].
    Niikura N; Kimura M; Kobayashi Y; Asahara F; Hayashi K; Shibata S; Shintoku J
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):1013-6. PubMed ID: 19542727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early phase II study of the new aromatase inhibitor YM511 in postmenopausal patients with breast cancer. Difficulty in clinical dose recommendation based on preclinical and phase I findings.
    Tominaga T; Suzuki T
    Anticancer Res; 2003; 23(4):3533-42. PubMed ID: 12926103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of breast cancer with multiple bone metastases demonstrating complete remission with high-dose toremifene therapy].
    Saito Y; Amano S; Kashio M; Abe H; Kuboi Y; Sakurai K; Aoki N; Hata S; Negishi N
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):911-4. PubMed ID: 15222111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Primary endocrine therapy as pre- and perimenopausal metastatic breast carcinoma with leuprorelin acetate depot. German Leuprorelin Study Group].
    Untch M
    Zentralbl Gynakol; 1998; 120(6):284-92. PubMed ID: 9659699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of lung and pleural metastases from breast cancer responding to toremifene].
    Inoue K; Tabei T; Kusawake T; Sugamata N; Suemasu K; Higashi Y; Kurosumi M
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):221-4. PubMed ID: 11242650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.
    Ardavanis A; Extra JM; Espié M; Cuvier C; Marty M
    In Vivo; 1998; 12(5):559-62. PubMed ID: 9827368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose toremifene in advanced renal-cell carcinoma.
    Gershanovich MM; Moiseyenko VM; Vorobjev AV; Käpylä H; Ellmén J; Anttila M
    Cancer Chemother Pharmacol; 1997; 39(6):547-51. PubMed ID: 9118468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse outcome and resistance to adjuvant antiestrogen therapy in node-positive postmenopausal breast cancer patients-The role of p53.
    Rahko E; Blanco G; Bloigu R; Soini Y; Talvensaari-Mattila A; Jukkola A
    Breast; 2006 Feb; 15(1):69-75. PubMed ID: 16005229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical trial of lentaron for postmenopausal patients with advanced breast cancer].
    Liu X; Song S; Jiang Z; Wu S; Yu J; Wang T
    Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):511-3. PubMed ID: 12485513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of refractory metastatic breast cancer with 5-fluorouracil plus levofolinic acid as continuous venous infusion: a phase II study.
    Gebbia V; Borsellino N; Testa A; Tirrito M; Varvara F; Cucchiara A; Mauceri G; Girlando A; Ferrara M; Caruso F
    Anticancer Res; 1999; 19(4C):3553-7. PubMed ID: 10629652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toremifene citrate (Fareston).
    Gerken P
    Clin J Oncol Nurs; 2004 Oct; 8(5):529-30. PubMed ID: 15565747
    [No Abstract]   [Full Text] [Related]  

  • 39. [A case of aromatase inhibitor-tolerant metastatic breast cancer revealing complete remission with high-dose toremifene therapy].
    Kurozumi S; Takeo T; Ikeda F; Horiguchi J; Takeyoshi I; Ito H
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):93-6. PubMed ID: 21368465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical benefit of high-dose toremifene for metastatic breast cancer.
    Koike K; Edo M; Higaki M; Kitahara K; Satou S; Noshiro H
    Gan To Kagaku Ryoho; 2013 Jul; 40(7):877-80. PubMed ID: 23863727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.